person · Reporting owner
Rootsaert Rodney Gerard
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | Secretary | March 17, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date March 17, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 273,993 |
Reported balance
After 2026-03-17 transaction · row 1
1 source rowRow 1 · 2026-03-17 · Tax withholding · Disposed 3,948 · Balance 273,993 F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,400 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction. |
| Common StockSEC Table I · non-derivative | IndirectBy Concord International, Inc. | 1,007,718 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,007,718 F2: The shares of common stock are held directly by Concord International, Inc. The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,400 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2: The shares of common stock are held directly by Concord International, Inc. The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2019 Filed Dec 18, 2019 16:49 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-19-000926 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2023-03-30 F1 · kind: The reported transactions involved a cancellation and reissuance of a portion of outstanding options upon agreement of the reporting person. The "old" options were originally granted on March 30, 2017 and vested in full at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested on the date of grant and have the same expiration date and exercise price as the "old" options. Read SEC document |
| December 16, 2019 Filed Sep 23, 2021 20:44 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001477932-21-006596 · form4.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2023-03-30 F1 · kind: The reported transactions involved a cancellation and reissuance of outstanding options upon agreement of the reporting person. The "old" options were originally granted on December 16, 2019, vested in full on the date of grant, and were exercisable until March 30, 2023. The "replacement" options are fully-vested on the date of grant and have an expiration date of March 30, 2027. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:28 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001078782-19-000127 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2025-02-11 F1 · derivative.exercise_date: A total of 50,000 Options were granted on February 11, 2019 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 6 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2021-07-23 F2 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 5 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2020-01-23 F2 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 4 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 3 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2020-08-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 2 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-02-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:58 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Disposition to issuerOption (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001078782-18-001448 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2019-02-18 F1 · kind: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020. Read SEC document |
| August 16, 2018 Filed Aug 17, 2018 14:42 UTC | VOLITIONRX LTD VNRX · Entity 8241 | PurchaseCommon Stock | 5,000 | $1.91 | $9,550.00 |
DisclosureSEC source: 0001078782-18-000887 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 22:10 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001078782-18-000071 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-01-23 F1 · derivative.exercise_date: A total of 50,000 Options were granted on January 23, 2018 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:11 UTC | VOLITIONRX LTD VNRX · Entity 8241 | PurchaseCommon Stock | 3,630 | $2.77 | $10,055.10 |
DisclosureSEC source: 0001078782-17-001161 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · Concord International, Inc. Disclosed balance after: 1,007,718 F1 · ownership.nature: The shares of Common Stock are held directly by Concord International, Inc. Mr. Rootsaert is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc. Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:33 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000413 · primary_doc.xml · derivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 60,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · derivative · entry 3 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Tax withholdingCommon Stock | 6,697 | $4.48 | $30,002.56 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · nonDerivative · entry 2 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,828 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:28 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionCommon Stock | 10,000 | $3.00 | $30,000.00 |
DisclosureSEC source: 0001078782-16-003846 · primary_doc.xml · nonDerivative · entry 1 Rootsaert Rodney Gerard · CIK 0001577894 · Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.